FindTrial
Sign In

Effect of Autologous Neural Stem Cells Transplantation on Patients with Cerebral Palsy

Effort of Neural Stem Cells Derived From Autologous Bone Marrow Mesenchymal Stem Cell on Patients with Cerebral Palsy for their Motor and Langurage Functions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002056
Enrollment
Unknown
Registered
2012-03-30
Start date
2010-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Interventions

Transplantation group:stem-cell transplantation
Control group:Conventional methods

Sponsors

Zhejiang Armed Police Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 30 Years

Inclusion criteria

Inclusion criteria: 1. Signed informed consent document; 2. Cerebral palsy patients with Gross Motor Function Classification System (GMFCS) levels III-V; 3. Their parents accepted voluntarily stem cell transplantation for their children and followed-up.

Exclusion criteria

Exclusion criteria: 1. Have a history of severe allergic; 2. Serological tests such as AIDS, hepatitis B, syphilis, etc; 3. Hereditary metabolic diseases of nervous system; 4. Tumor or Hematological diseases.

Design outcomes

Primary

MeasureTime frame
GMFM socres;Language development quotient;—

Countries

China

Contacts

Public ContactGuojun Chen
guoyouchenwj@163.com+86 13817290501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026